Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.

MLA

Goldman, Adam, et al. “Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.” Journal of the American College of Cardiology, vol. 78, no. 18, Nov. 2021, pp. 1800–13. EBSCOhost, https://doi.org/10.1016/j.jacc.2021.08.044.

APA

Goldman, A., Maor, E., Bomze, D., Liu, J. E., Herrmann, J., Fein, J., Steingart, R. M., Mahmood, S. S., Schaffer, W. L., Perales, M.-A., & Shouval, R. (2021). Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy. Journal of the American College of Cardiology, 78(18), 1800–1813. https://doi.org/10.1016/j.jacc.2021.08.044

Chicago

Goldman, Adam, Elad Maor, David Bomze, Jennifer E Liu, Joerg Herrmann, Joshua Fein, Richard M Steingart, et al. 2021. “Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.” Journal of the American College of Cardiology 78 (18): 1800–1813. doi:10.1016/j.jacc.2021.08.044.